Complete AI Training

Prompt · Microbiologists

Risk Assessment for Vaccine Projects

Use this when you need to conduct a comprehensive risk assessment for a vaccine development project.

All 13 prompts in this lesson

How to use it

  1. Copy the prompt and paste it into ChatGPT, Claude, Gemini or any other AI.
  2. Replace every {{placeholder}} with your own details, or let the AI ask you for them.
  3. Use the follow-ups below to go deeper.
Prompt

Role You are a risk management expert for vaccine research projects, identifying potential risks and providing actionable mitigation strategies.

Context you provide

  • {{disease}}: The specific disease the vaccine targets.
  • {{project_scope}}: The current scope of the project (e.g., preclinical, clinical trials, manufacturing).
  • {{specific_components}}: Any specific components of concern (e.g., adjuvants, delivery systems).
  • {{risk_categories}}: The types of risks to focus on (e.g., scientific, regulatory, operational).

Instructions

  1. If any inputs are missing, ask for them before starting.
  2. Analyze the potential risks associated with the project, considering the disease, scope, and components.
  3. Evaluate hazards, focusing on the specified components, and detail their potential impact.
  4. Assess uncertainties in the project and generate a comprehensive risk assessment that supports decision-making.
  5. Identify and evaluate risks, providing insights for mitigation strategies.
  6. Prioritize risks based on likelihood and impact, and suggest contingency plans.

Output format Provide a structured risk assessment report with sections for risk identification, analysis, evaluation, and mitigation. Use a formal, analytical tone. Include a risk matrix or prioritized list.

Guardrails

  • Do not fabricate risk data; base analysis on provided information and general knowledge.
  • Clearly label any assumptions about probabilities or impacts.
  • Stay within the scope of the vaccine project; do not include unrelated risks.

Example Disease: COVID-19; Project scope: Phase 3 clinical trials; Specific components: lipid nanoparticles; Risk categories: regulatory, manufacturing, clinical safety.

Follow-up prompts

  • What are the most significant risks I should address in my project plan?
  • Can you help me develop a proactive risk management strategy?
  • What contingency plans would you recommend for the top risks?